Comparison of Long-term Outcomes of Infliximab versus Adalimumab in 1,488 Biologic-Naive Korean Patients with Crohn’s Disease
Background/Aims: Data on the comparative effectiveness of infliximab (IFX) or adalimumab (ADA) in patients with Crohn’s disease (CD) are rare, particularly for Asian patients. We compared the key clinical outcomes (surgery, hospitalization, and corticosteroid use) of use of these two drugs in biolog...
Gardado en:
| Principais autores: | , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Gastroenterology Council for Gut and Liver
2021-01-01
|
| Series: | Gut and Liver |
| Assuntos: | |
| Acceso en liña: | http://gutnliver.org/journal/view.html?doi=10.5009/gnl19377 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|